title: Epidural analgesia with a combination of bupivacaine and buprenorphine in rats.
abstract: We determined the analgesic effects of epidural administration of either bupivacaine at 62.5, 125, 250, and 500 micrograms/kg; buprenorphine at 5 and 10 micrograms/kg; and the combination of bupivacaine at 125 micrograms/kg and buprenorphine at 5 or 10 micrograms/kg, using the tail flick (TF) and colorectal distension (CD) tests in rats and compared the results with those obtained using morphine at 100 micrograms/kg. In both the TF and CD tests, all doses of bupivacaine alone produced potent anti-nociceptive effects, although the effect rapidly diminished after 20-30 min of administration. The administration of buprenorphine at 10 and 5 micrograms/kg produced mild to moderate anti-nociceptive effects in both the TF and CD tests, and the effects were relatively constant throughout the 2-h experimental period. Combinations of 5 or 10 micrograms/kg of buprenorphine with 125 mg/kg of bupivacaine produced a significantly higher percentage of maximum possible analgesic effect (%MPE) than that of the calculated additive effect of each drug alone in the TF and CD tests. The analgesic effect of this combination was similar to that of morphine. Minimal ataxia was observed in rats administered this combination.
authors.affiliation: Laboratory of Veterinary Surgery, Division of Veterinary Medical Science, Graduate School of Agricultural and Life Sciences, University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Morimoto
authors.forename: R
authors.initials: R
authors.lastname: Nishimura
authors.forename: S
authors.initials: S
authors.lastname: Matsunaga
authors.forename: M
authors.initials: M
authors.lastname: Mochizuki
authors.forename: N
authors.initials: N
authors.lastname: Sasaki
mesh_terms: D015360:Analgesia, Epidural / Q000662:veterinary*; D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D002045:Bupivacaine / Q000008:administration & dosage / Q000494:pharmacology*; D002047:Buprenorphine / Q000008:administration & dosage / Q000494:pharmacology*; D004359:Drug Therapy, Combination; D008297:Male; D009043:Motor Activity / Q000187:drug effects*; D010146:Pain / Q000517:prevention & control; D010147:Pain Measurement / Q000187:drug effects; D051381:Rats; D017207:Rats, Sprague-Dawley / Q000502:physiology*
chemical_list: D000701:Analgesics, Opioid; D002047:Buprenorphine; D002045:Bupivacaine